Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial

Dementia and Geriatric Cognitive Disorders

Volumn 43, Issue 1-2, 2017, Pages 100-117

  Reisberg, Barry ^a   Shao, Yongzhao ^a   Golomb, James ^a   Monteiro, Isabel ^a   Torossian, Carol ^a   Boksay, Istvan ^a   Shulman, Melanie ^a   Heller, Sloane ^a   Zhu, Zhaoyin ^a   Atif, Ayesha ^a   Sidhu, Jaskirat ^a   Vedvyas, Alok ^a   Kenowsky, Sunnie ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Activities of daily living; Behavioral symptoms; Caregivers; Community health care; Community health education; Comprehensive health care; Delivery of health care; Dementia; Patient centered care; Person centered therapy

Indexed keywords

MEMANTINE; PLACEBO; NOOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CAREGIVER SUPPORT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMMUNITY CARE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EXERCISE; FEMALE; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; CASE MANAGEMENT; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PERSONALIZED MEDICINE; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; CASE MANAGEMENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMANTINE; MIDDLE AGED; NOOTROPIC AGENTS; PRECISION MEDICINE; TREATMENT OUTCOME;

EID: 85010851203     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000455397     Document Type: Article

References (47)

1. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; for the Memantine Study Group: Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348: 1333-1341
2. Winblad B, Poritis N: Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999; 14: 135-146
3. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group: Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004; 291: 317-324
4. Finkel SI: Behavioral and psychological signs and symptoms of dementia: implications for research and treatment. Proceedings of an international consensus conference. Lansdowne, Virginia, April 1996. Int Psychogeriatr 1996; 8(suppl 3):215-552
5. Finkel SI, Burns A: Behavioral and Psychological Symptoms of Dementia (BPSD): a clinical and research update. Int Psychogeriatr 2000; 12(suppl 1):9-424
6. Reisberg B, Monteiro I, Torossian C, Auer S, Shulman MB, Ghimire S, Boksay I, Guillo BenArous F, Osorio R, Vengassery A, Imran S, Shaker H, Noor S, Naqvi S, Kenowsky S, Xu J: The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review. Dement Geriatr Cogn Disord 2014; 38: 89-146
7. Brodaty H, McGilchrist C, Harris L, Peters KE: Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors. Arch Neurol 1993; 50: 643-650
8. Mittelman MS, Haley WE, Clay OJ, Roth DL: Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology 2006; 67: 1592-1599
9. Metitieri T, Zanetti O, Geroldi C, Frisoni GB, De Leo D, Dello Buono M, Bianchetti A, Trabucchi M: Reality orientation therapy to delay outcomes of progression in patients with dementia. A retrospective study. Clin Rehabil 2001; 15: 471-478
10. Brotons M, Marti P: Music therapy with Alzheimer's patients and their family caregivers: a pilot project. J Music Ther 2003; 40: 138-150
11. Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L: Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 2003; 11: 194-203
12. Zeisel J, Silverstein NM, Hyde J, Levkoff S, Lawton MP, Holmes W: Environmental correlates to behavioral health outcomes in Alzheimer's special care units. Gerontologist 2003; 43: 697-711
13. Neal M, Briggs M: Validation therapy for dementia. Cochrane Database Syst Rev 2003;CD001394
14. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB: Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 2003; 290: 2015-2022
15. Luijpen MW, Scherder EJ, Van Someren EJ, Swaab DF, Sergeant JA: Non-pharmacological interventions in cognitively impaired and demented patients: a comparison with cholinesterase inhibitors. Rev Neurosci 2003; 14: 343-368
16. Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldman HH, Muñiz R: Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 2010; 30: 161-178
17. Reisberg B, Franssen EH, Souren LEM, Auer SR, Akram I, Kenowsky S: Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import. Am J Alzheimers Dis Other Demen 2002; 17: 202-212
18. Reisberg B, Javed A, Kenowsky S, Auer SR: Alzheimer's disease; in Zaretsky HH, Richter EF III, Eisenberg MG (eds): Medical Aspects of Disability, ed 3. New York, Springer, 2005, pp 79-118
19. Kitwood T, Bredin K: Towards a theory of dementia care: personhood and well-being. Ageing Soc 1992; 12: 269-287
20. Kenowsky S: What aspects of behavioral disturbances are important to caregivers? Perspective of a family caregiver. Int Psychogeriatr 1996; 8(suppl 3):449-453
21. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guideline: guideline for good clinical practice. 1996. E6(R1).http:// www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E6/E6-R1-Guideline.pdf
22. World Medical Association: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-2194
23. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders, ed 4, text revision (DSM-IV-TR). Washington, American Psychiatric Association, 2000
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944
25. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139
26. Sclan SG, Reisberg B: Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity and ordinality. Int Psychogeriatr 1992; 4: 55-69
27. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of persons for the clinician. J Psychiatr Res 1975; 12: 189-198
28. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7: 486-488
29. Department of Health and Human Services National Institute of Health: Alzheimer's Disease: Unraveling the Mystery. NIH Publication Number 02-3782, December 2002. http://www.nia.nih.gov/HealthInformation/ Publications
30. Reisberg B, Kenowsky S, Franssen EH, Auer SR, Souren LEM: President's report: towards a science of Alzheimer's disease management: a model based upon current knowledge of retrogenesis. Int Psychogeriatr 1999; 11: 7-23
31. Reisberg B, Franssen EH: Clinical stages of Alzheimer's disease; in de Leon MJ (ed): An Atlas of Alzheimer's Disease. Carnforth, Parthenon, 1999, pp 11-20
32. Reisberg B, London E, Ferris SH, Borenstein J, Scheier L, Leon MJ: The Brief Cognitive Rating Scale: language, motoric, and mood concomitants in primary degenerative dementia. Psychpharmacol Bull 1983; 19: 702-708
33. Reisberg B, Ferris SH, Leon MJ, Sinaiko E, Franssen E, Kluger A, Mir P, Borenstein J, George AE, Shulman E, Steinberg G, Cohen J: Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type. Drug Dev Res 1988; 15: 101-114
34. Reisberg B, Auer SR, Monteiro I, Franssen E, Kenowsky S: A rational psychological approach to the treatment of behavioral disturbances and symptomatology in Alzheimer's disease based upon recognition of the developmental age. Int Acad Biomed Drug Res 1998; 13: 102-109
35. Teri L, Logsdon RG, McCurry SM: Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am 2002; 86: 641-656
36. Reisberg B, Franssen E, Sclan SG, Kluger A, Ferris SH: Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer's disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci 1989; 54: 95-112
37. McKitrick LA, Camp C, Black FW: Prospective memory intervention in Alzheimer's disease. J Gerontol 1992; 47: 337-343
38. Franssen EH, Souren LEM, Torossian CL, Reisberg B: Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease. J Am Geriatr Soc 1999; 47: 463-469
39. Franssen EH, Kluger A, Torossian CL, Reisberg B: The neurologic syndrome of severe Alzheimer's disease: relationship to functional decline. Arch Neurol 1993; 50: 1029-1039
40. Souren LEM, Franssen EM, Reisberg B: Contractures and loss of function in patients with Alzheimer's disease. J Am Geriatr Soc 1995; 43: 650-655
41. Reisberg B, Saeed MU: Alzheimer's disease; in Sadovoy J, Jarvik LF, Grossberg GT, Meyers BS (eds): Comprehensive Textbook of Geriatric Psychiatry, ed 3. New York, Norton, 2004, pp 449-509
42. Reisberg B: Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr 2007; 19: 421-456
43. Galasko DR, Schmitt FA, Jin S, Saxton J, Bennett D, Sano M, Ferris SH: Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease. Neurobiol Aging 2000; 21:(suppl 1):168
44. Panisset M, Roudier M, Saxton J, Boller F: Severe impairment battery. A neuropsychological test for severely demented patients. Arch Neurol 1994; 51: 41-45
45. Monteiro IM, Boksay I, Auer SR, Torossian C, Ferris SH, Reisberg B: Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability. Eur Psychiatry 2001; 16(suppl 1):5s-24s
46. Teri L, Truax P, Logsdon R, Uomoto J, Zarit S, Vitaliano PP: Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist (RMBPC). Psychol Aging 1992; 7: 622-631
47. Reisberg B, Franssen E, Souren L, Kenowsky S, Janjua K, Veigne S, Guillo Benarous F, Singh S, Khizar A, Shah U, Shah R, Bhandal A, Auer S: Alzheimer's disease; in Moroz A, Flanagan SR, Zaretsky H (eds): Medical Aspects of Disability, ed 5. New York, Springer, 2017, pp 31-90